The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Terns Pharmaceuticals Inc shares valued at $25,607 were sold by Kuriakose Emil on Jan 02 ’25. At $5.71 per share, Kuriakose Emil sold 4,481 shares. The insider’s holdings dropped to 54,269 shares worth approximately $0.25 million following the completion of this transaction.
Also, Vignola Mark J. sold 9,059 shares, netting a total of over 52,500 in proceeds. Following the sale of shares at $5.80 each, the insider now holds 74,752 shares.
Before that, Vignola Mark J. had sold 8,129 shares from its account. In a trade valued at $46,524, the Chief Financial Officer traded Terns Pharmaceuticals Inc shares for $5.72 each. Upon closing the transaction, the insider’s holdings decreased to 8,129 shares, worth approximately $0.39 million.
As published in their initiating research note from Oppenheimer on October 31, 2024, Terns Pharmaceuticals Inc [TERN] has been an Outperform and the price target has been revised to $82. Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 07, 2023, Jefferies has initiated its “Buy” rating for TERN. Earlier on May 31, 2023, ROTH MKM initiated its rating. Their recommendation was “a Buy” for TERN stock.
Analyzing TERN Stock Performance
Over the course of the year, Terns Pharmaceuticals Inc shares have dropped approximately -16.25%. Shares of the company reached a 52-week high of $5.95 on 01/06/25 and a 52-week low of $4.16 on 01/29/25. A 50-day SMA is recorded $5.66, while a 200-day SMA reached $6.88. Nevertheless, trading volume fell to 2.16 million shares from 2.11 million shares the previous day.
Support And Resistance Levels for Terns Pharmaceuticals Inc (TERN)
According to the 24-hour chart, there is a support level at 4.33, which, if violated, would cause prices to drop to 4.03. In the upper region, resistance lies at 4.83. The next price resistance is at 5.03. RSI (Relative Strength Index) is 40.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.15, which suggests the price will decrease in the coming days. Percent R is at 52.02%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
